Pluristem Therapeutics Inc (PSTI)

[n3m3sis]

The question now is are Pluristem near enough to commercialisation to get the jump on Celularity, given the vast resources that are backing the new Celgene spin-off?

Will Pluristem respond to the threat this poses and if so, how?

Does anyone believe that this spin-off company has come into being from
Pluristems refusal to be either bought out or merge with one of the BIG P companies?

Please discuss if you will, without resorting to insults or hubris, remembering to be courteous to your fellow posters, whether you agree with their views or not.

GLTA

n3m